141 related articles for article (PubMed ID: 26796900)
1. FDA approves therapy to treat overdose of fluorouracil, capecitabine.
Traynor K
Am J Health Syst Pharm; 2016 Feb; 73(3):100, 102. PubMed ID: 26796900
[No Abstract] [Full Text] [Related]
2. Vistogard (Uridine Triacetate): The First and Only Drug Approved for the Treatment of 5-Fluorouracil or Capecitabine Overdose: Implications for the Clinical Nurse Specialist.
O'Malley PA
Clin Nurse Spec; 2016; 30(3):145-7; quiz E11. PubMed ID: 27055035
[No Abstract] [Full Text] [Related]
3. FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs.
Ison G; Beaver JA; McGuinn WD; Palmby TR; Dinin J; Charlab R; Marathe A; Jin R; Liu Q; Chen XH; Ysern X; Stephens O; Bai G; Wang Y; Dorff SE; Cheng J; Tang S; Sridhara R; Pierce W; McKee AE; Ibrahim A; Kim G; Pazdur R
Clin Cancer Res; 2016 Sep; 22(18):4545-9. PubMed ID: 27401247
[TBL] [Abstract][Full Text] [Related]
4. Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.
Ma WW; Saif MW; El-Rayes BF; Fakih MG; Cartwright TH; Posey JA; King TR; von Borstel RW; Bamat MK
Cancer; 2017 Jan; 123(2):345-356. PubMed ID: 27622829
[TBL] [Abstract][Full Text] [Related]
5. Case report of capecitabine toxicity and use of uridine triacetate.
Oliver WD; Duffy AP; Hausner PF
J Oncol Pharm Pract; 2019 Mar; 25(2):470-473. PubMed ID: 28942723
[TBL] [Abstract][Full Text] [Related]
6. Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature.
Zurayk M; Keung YK; Yu D; Hu EH
J Oncol Pharm Pract; 2019 Jan; 25(1):234-238. PubMed ID: 28950804
[TBL] [Abstract][Full Text] [Related]
7. Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency.
Garcia RAG; Saydoff JA; Bamat MK; von Borstel RW
Toxicol Appl Pharmacol; 2018 Aug; 353():67-73. PubMed ID: 29908244
[TBL] [Abstract][Full Text] [Related]
8. In brief: uridine triacetate (Vistogard) for fluorouracil overdose.
Med Lett Drugs Ther; 2016 Jul; 58(1498):90. PubMed ID: 27348145
[No Abstract] [Full Text] [Related]
9. An antidote to fluorouracil and capecitabine toxicity.
Wilkinson E
Lancet Oncol; 2016 Oct; 17(10):e429. PubMed ID: 27667571
[No Abstract] [Full Text] [Related]
10. The successful treatment of 5-fluorouracil (5-FU) overdose in a patient with malignancy and HIV/AIDS with uridine triacetate.
Santos C; Morgan BW; Geller RJ
Am J Emerg Med; 2017 May; 35(5):802.e7-802.e8. PubMed ID: 27884585
[TBL] [Abstract][Full Text] [Related]
11. Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?
Lampropoulou DI; Laschos K; Amylidi AL; Angelaki A; Soupos N; Boumpoucheropoulos S; Papadopoulou E; Nanou E; Zidianakis V; Nasioulas G; Fildissis G; Aravantinos G
J Oncol Pharm Pract; 2020 Apr; 26(3):747-753. PubMed ID: 31382864
[TBL] [Abstract][Full Text] [Related]
12. Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency.
Saif MW; Diasio RB
Cancer Chemother Pharmacol; 2016 Jul; 78(1):151-6. PubMed ID: 27278667
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil and Capecitabine: Assessment and Treatment of Uncommon Early-Onset Severe Toxicities Associated With Administration.
Brutcher E; Christensen D; Hennessey Smith M; Koutlas JB; Sellers JB; Timmons T; Thompson J
Clin J Oncol Nurs; 2018 Dec; 22(6):627-634. PubMed ID: 30451997
[TBL] [Abstract][Full Text] [Related]
14. [5-FU: At last!].
Robert J
Bull Cancer; 2019 Mar; 106(3):173-174. PubMed ID: 30837157
[No Abstract] [Full Text] [Related]
15. Early-Onset 5-Fluorouracil Toxicity in a Patient Negative for Dihydropyrimidine Dehydrogenase Mutations: The Clinical Course of Reversal with Uridine Triacetate.
Vaudo CE; Gil B; Galuski K; Zarwan C; Nugent FW
Pharmacotherapy; 2016 Nov; 36(11):e178-e182. PubMed ID: 27716991
[TBL] [Abstract][Full Text] [Related]
16. Real-time comprehensive toxicology testing in the clinical management of accidental pediatric capecitabine ingestion.
Gintjee TJ; Goodnough R; Li K; Badea A; Lynch KL; Garcia E; Repplinger D
J Oncol Pharm Pract; 2020 Oct; 26(7):1759-1761. PubMed ID: 32089072
[TBL] [Abstract][Full Text] [Related]
17. Use of uridine triacetate for the management of fluorouracil overdose.
McEvilly M; Popelas C; Tremmel B
Am J Health Syst Pharm; 2011 Oct; 68(19):1806-9. PubMed ID: 21930638
[TBL] [Abstract][Full Text] [Related]
18. In brief: Uridine triacetate (Xuriden) for hereditary orotic aciduria.
Med Lett Drugs Ther; 2016 Mar; 58(1491):e49. PubMed ID: 27027693
[No Abstract] [Full Text] [Related]
19. Two patients with fluoropyrimidine overdose successfully managed without uridine triacetate.
Kats CJ; Jochems A; Jeurissen FJ; Ledeboer A; van den Berg RB
J Oncol Pharm Pract; 2023 Dec; 29(8):2037-2040. PubMed ID: 37499216
[TBL] [Abstract][Full Text] [Related]
20. Fluorouracil: dosing errors with infusion pumps.
Prescrire Int; 2014 Oct; 23(153):242. PubMed ID: 25969854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
